4.6 Article

Role of Nutrient-sensing Receptor GPRC6A in Regulating Colonic Group 3 Innate Lymphoid Cells and Inflamed Mucosal Healing

Journal

JOURNAL OF CROHNS & COLITIS
Volume 16, Issue 8, Pages 1293-1305

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ecco-jcc/jjac020

Keywords

GPRC6A; L-arginine; ILC3; IL-22; mTORC1; colitis

Funding

  1. National Key R&D Program of China [2017YFE0129900]

Ask authors/readers for more resources

This study found that the nutrient-sensing receptor GPRC6A plays an important role in the function of ILC3s in the gut and identified a novel ILC3 receptor signaling pathway that modulates inflamed mucosal healing.
Background and Aims Group 3 innate lymphoid cells [ILC3s] sense environmental signals and are critical in gut homeostasis and immune defence. G-protein-coupled receptors [GPCRs] mediate cellular responses to diverse environmental signals. However, the GPCRs' regulation mechanisms of ILC3s is largely unknown. Methods We used wild-type [WT] and GPRC6A(-/-) mice to investigate the role of GPRC6A in the population and the function of ILC3s. We then purified ILC3s from WT and GPRC6A(-/-) mice. Colitis was induced in WT mice and GPRC6A(-/-) mice through dextran sodium sulphate [DSS] administration or C. rodentium infection. Furthermore L-arginine, a selective GPRC6A agonist, was administered to mice with colitis. Results We found that colonic ILC3s expressed GPRC6A. The deficiency of GPRC6A decreased ILC3-derived interleukin-22 [IL-22] production and the number of proliferating ILC3s, which led to increased susceptibility to colon injury and pathogen infection and impaired inflamed mucosal healing. Further studies showed that L-arginine, a GPRC6A agonist, promoted colonic ILC3 expansion and function via the mammalian target of rapamycin complex 1 [mTORC1] signalling in vitro. In addition, L-arginine attenuated DSS-induced colitis in vivo. This was associated with a significant increase in IL-22 secretion by ILC3s. Conclusions Our findings unveil a role for the nutrient-sensing receptor GPRC6A in colonic ILC3 function and identify a novel ILC3 receptor signalling pathway modulating inflamed mucosal healing.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available